Received May 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z003310 | — |
No symptoms reported.; patient erroneously received a dose of PROQUAD instead of MMRII; This spontaneous report was received from a/an Nurse and refers to a(n) 66-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 21-May-2025, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z003310, expiration date: 21-Jul-2026) 0.5 mL (0.5ML),. On 21-May-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), (lot # and expiration date were not reported). The patient started therapy with sterile diluent (MERCK STERILE DILUENT), for the treatment of prophylaxis. The patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), for the treatment of Prophylaxis. On 21-May-2025, the patient experienced patient erroneously received a dose of PROQUAD instead of MMRII. On an unknown date, the patient experienced No symptoms reported. Lot # is being requested and will be submitted if received.
Diluent Mrk